New share capital registered

New share capital registered

Issuer

Thor Medical ASA

2.5.2024 13:59:41 CEST | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state

Reference is made to the stock exchange announcements made by Thor Medical ASA
(the "Company") on 21 April 2024 regarding issuance of 1,320,469 new shares to
members of the board. The share issue has now been registered in the Norwegian
Register of Business Enterprises and the Company's new share capital is NOK
46,971,895 dividend into 234,859,475 shares, each with a nominal value of NOK
0.20. Each share represents one vote in the Company's general meeting.

DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.

CONTACTS

* Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
[email protected]

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visitwww.thormedical.no - https://www.thormedical.no.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/3079/4415/Download%20announcement
%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

617572_Download announcement as PDF.pdf